探索SGLT2抑制剂在乳腺癌中的活性:概述
Ritesh P Bhole1,2, Gayatri S Maldhure1, Harshad S Kapare1
1Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018.
Current topics in medicinal chemistry
|April 15, 2025
概括
-葡萄糖共运输体2 (SGLT2) 抑制剂通过诱导亡并改变癌细胞的葡萄糖吸收,在治疗乳腺癌方面表现有前途. 需要进一步的临床研究来确认它们的安全性和有效性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- 主要用于糖尿病的-葡萄糖共运输体2 (SGLT2) 抑制剂正在成为潜在的乳腺癌治疗药物.
- 它们的机制包括诱导癌细胞亡和减少葡萄糖吸收.
研究的目的:
- 研究SGLT2抑制剂对乳腺癌细胞的抗癌作用.
- 探索它们与常规化疗的协同作用潜力.
- 审查它们在乳腺癌治疗和精准医学中的作用.
主要方法:
- 在体外和体内测试四种SGLT2抑制剂:达帕格利弗洛辛,伊普拉格利弗洛辛,卡纳格利弗洛辛和恩帕格利弗洛辛.
- 对亡,葡萄糖吸收和关键信号通路 (PI3K/AKT/mTOR,MAPK) 的影响分析.
- 检查与化疗剂的协同效应.
主要成果:
- SGLT2 抑制剂表现出诱导亡和降低乳腺癌细胞中葡萄糖吸收的能力.
- 观察到PI3K/AKT/mTOR和MAPK信号通路的调节.
- 表明了与常规化疗有协同效应的可能性.
结论:
- SGLT2 抑制剂代表了乳腺癌的有希望的治疗途径,影响关键的癌细胞过程.
- 进一步的临床试验对于确定乳腺癌患者的安全性和疗效至关重要.
- 与精准医学策略的整合可能会提高治疗结果.
关键词:
SGLT2 (-葡萄糖共运输体2) 抑制剂的使用.乳腺癌 乳腺癌 乳腺癌可以使用Canagliflozin.达帕格利弗洛辛 (Dapagliflozin) 是一种这就是Empagliflozin.伊普拉格利弗洛辛 (ipragliflozin) 是一种一种更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.6K
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.2K
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
141
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
141
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Secondary Active Transport
6.6K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
6.6K
Dipeptidyl Peptidase 4 Inhibitors
134
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
134
Selectins
3.2K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.2K
